EARLY HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANTATION IN PATIENTS WITH HIGH-RISK, AGGRESSIVENON-HODGKINS-LYMPHOMA
W. Brugger et al., EARLY HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANTATION IN PATIENTS WITH HIGH-RISK, AGGRESSIVENON-HODGKINS-LYMPHOMA, Blood, 84(10), 1994, pp. 10000234-10000234